In HNSCC, Pifer et al. found that the FAK inhibitor increased sensitivity to radiation, enhanced DNA damage, and suppressed homologous recombination and nonhomologous end joining repair in the TP53 mutant, but not wild-type, HPV-negative HNSCC cell lines. This evidence concerns the gene PTK2 and head and neck squamous cell carcinoma.